Interdisciplinary development of an intravenous infusion protocol for Orthoclone OKT3
The development and implementation of an infusion protocol for Orthoclone OKT3 (Ortho Biotech, Inc., Raritan, NJ) is described in this article. OKT3 is a potent immunosuppressant drug used to lower the incidence of graft rejection in transplant patients. Nurses and physicians use the protocol descri...
Gespeichert in:
| Veröffentlicht in: | Journal of intravenous nursing 1996-05, Vol.19 (3), p.117-121 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 121 |
|---|---|
| container_issue | 3 |
| container_start_page | 117 |
| container_title | Journal of intravenous nursing |
| container_volume | 19 |
| creator | Byrd, J G Raulinaitis, A Burke, P B Welsh, D |
| description | The development and implementation of an infusion protocol for Orthoclone OKT3 (Ortho Biotech, Inc., Raritan, NJ) is described in this article. OKT3 is a potent immunosuppressant drug used to lower the incidence of graft rejection in transplant patients. Nurses and physicians use the protocol described in this article to administer OKT3 to heart and lung transplant patients at our institution. Pharmacokinetics, along with the nursing care, associated with OKT3 administration are described in the protocol section. The benefits of protocol use are reported in the conclusion. |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_78296577</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78296577</sourcerecordid><originalsourceid>FETCH-LOGICAL-p538-a6a265c616882f3cd811a718d052f50430d88ec72c1c3dfceccc67a4230ed6813</originalsourceid><addsrcrecordid>eNotkE1LxDAYhHNQ1nX1Jwg5eSskTZu8e5TFj8WFXuq5xOQNVtKkJu2C_96Ae5o5DMMzc0W2DPayaqGRN-Q252_GuBICNmQDCgBq2JKPY1gw2TGbcfZj0OmXWjyjj_OEYaHRUR3oGJakzxjimot3ax5joHOKSzTRUxcT7dLyFY2PAWn33os7cu20z3h_0R3pX577w1t16l6Ph6dTNbcCKi11LVsjuSwsThgLnGvFwbK2di1rBLMAaFRtuBHWGTTGSKWbWjC0ErjYkcf_2sLys2JehqkMQe91wMI6KKj3slWqBB8uwfVzQjvMaZzK1OFyg_gDw3hZhg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78296577</pqid></control><display><type>article</type><title>Interdisciplinary development of an intravenous infusion protocol for Orthoclone OKT3</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Byrd, J G ; Raulinaitis, A ; Burke, P B ; Welsh, D</creator><creatorcontrib>Byrd, J G ; Raulinaitis, A ; Burke, P B ; Welsh, D</creatorcontrib><description>The development and implementation of an infusion protocol for Orthoclone OKT3 (Ortho Biotech, Inc., Raritan, NJ) is described in this article. OKT3 is a potent immunosuppressant drug used to lower the incidence of graft rejection in transplant patients. Nurses and physicians use the protocol described in this article to administer OKT3 to heart and lung transplant patients at our institution. Pharmacokinetics, along with the nursing care, associated with OKT3 administration are described in the protocol section. The benefits of protocol use are reported in the conclusion.</description><identifier>ISSN: 0896-5846</identifier><identifier>PMID: 8788828</identifier><language>eng</language><publisher>United States</publisher><subject>Humans ; Immunosuppressive Agents - therapeutic use ; Infusions, Intravenous ; Muromonab-CD3 - therapeutic use ; Nursing ; Nursing Records ; Patient Care Planning ; Patient Care Team</subject><ispartof>Journal of intravenous nursing, 1996-05, Vol.19 (3), p.117-121</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8788828$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Byrd, J G</creatorcontrib><creatorcontrib>Raulinaitis, A</creatorcontrib><creatorcontrib>Burke, P B</creatorcontrib><creatorcontrib>Welsh, D</creatorcontrib><title>Interdisciplinary development of an intravenous infusion protocol for Orthoclone OKT3</title><title>Journal of intravenous nursing</title><addtitle>J Intraven Nurs</addtitle><description>The development and implementation of an infusion protocol for Orthoclone OKT3 (Ortho Biotech, Inc., Raritan, NJ) is described in this article. OKT3 is a potent immunosuppressant drug used to lower the incidence of graft rejection in transplant patients. Nurses and physicians use the protocol described in this article to administer OKT3 to heart and lung transplant patients at our institution. Pharmacokinetics, along with the nursing care, associated with OKT3 administration are described in the protocol section. The benefits of protocol use are reported in the conclusion.</description><subject>Humans</subject><subject>Immunosuppressive Agents - therapeutic use</subject><subject>Infusions, Intravenous</subject><subject>Muromonab-CD3 - therapeutic use</subject><subject>Nursing</subject><subject>Nursing Records</subject><subject>Patient Care Planning</subject><subject>Patient Care Team</subject><issn>0896-5846</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNotkE1LxDAYhHNQ1nX1Jwg5eSskTZu8e5TFj8WFXuq5xOQNVtKkJu2C_96Ae5o5DMMzc0W2DPayaqGRN-Q252_GuBICNmQDCgBq2JKPY1gw2TGbcfZj0OmXWjyjj_OEYaHRUR3oGJakzxjimot3ax5joHOKSzTRUxcT7dLyFY2PAWn33os7cu20z3h_0R3pX577w1t16l6Ph6dTNbcCKi11LVsjuSwsThgLnGvFwbK2di1rBLMAaFRtuBHWGTTGSKWbWjC0ErjYkcf_2sLys2JehqkMQe91wMI6KKj3slWqBB8uwfVzQjvMaZzK1OFyg_gDw3hZhg</recordid><startdate>199605</startdate><enddate>199605</enddate><creator>Byrd, J G</creator><creator>Raulinaitis, A</creator><creator>Burke, P B</creator><creator>Welsh, D</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>199605</creationdate><title>Interdisciplinary development of an intravenous infusion protocol for Orthoclone OKT3</title><author>Byrd, J G ; Raulinaitis, A ; Burke, P B ; Welsh, D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p538-a6a265c616882f3cd811a718d052f50430d88ec72c1c3dfceccc67a4230ed6813</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Humans</topic><topic>Immunosuppressive Agents - therapeutic use</topic><topic>Infusions, Intravenous</topic><topic>Muromonab-CD3 - therapeutic use</topic><topic>Nursing</topic><topic>Nursing Records</topic><topic>Patient Care Planning</topic><topic>Patient Care Team</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Byrd, J G</creatorcontrib><creatorcontrib>Raulinaitis, A</creatorcontrib><creatorcontrib>Burke, P B</creatorcontrib><creatorcontrib>Welsh, D</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of intravenous nursing</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Byrd, J G</au><au>Raulinaitis, A</au><au>Burke, P B</au><au>Welsh, D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Interdisciplinary development of an intravenous infusion protocol for Orthoclone OKT3</atitle><jtitle>Journal of intravenous nursing</jtitle><addtitle>J Intraven Nurs</addtitle><date>1996-05</date><risdate>1996</risdate><volume>19</volume><issue>3</issue><spage>117</spage><epage>121</epage><pages>117-121</pages><issn>0896-5846</issn><abstract>The development and implementation of an infusion protocol for Orthoclone OKT3 (Ortho Biotech, Inc., Raritan, NJ) is described in this article. OKT3 is a potent immunosuppressant drug used to lower the incidence of graft rejection in transplant patients. Nurses and physicians use the protocol described in this article to administer OKT3 to heart and lung transplant patients at our institution. Pharmacokinetics, along with the nursing care, associated with OKT3 administration are described in the protocol section. The benefits of protocol use are reported in the conclusion.</abstract><cop>United States</cop><pmid>8788828</pmid><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0896-5846 |
| ispartof | Journal of intravenous nursing, 1996-05, Vol.19 (3), p.117-121 |
| issn | 0896-5846 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_78296577 |
| source | MEDLINE; Journals@Ovid Complete |
| subjects | Humans Immunosuppressive Agents - therapeutic use Infusions, Intravenous Muromonab-CD3 - therapeutic use Nursing Nursing Records Patient Care Planning Patient Care Team |
| title | Interdisciplinary development of an intravenous infusion protocol for Orthoclone OKT3 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T04%3A08%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Interdisciplinary%20development%20of%20an%20intravenous%20infusion%20protocol%20for%20Orthoclone%20OKT3&rft.jtitle=Journal%20of%20intravenous%20nursing&rft.au=Byrd,%20J%20G&rft.date=1996-05&rft.volume=19&rft.issue=3&rft.spage=117&rft.epage=121&rft.pages=117-121&rft.issn=0896-5846&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E78296577%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78296577&rft_id=info:pmid/8788828&rfr_iscdi=true |